Brian Cheng

Title: Brian Cheng - Innovator in Enzyme Assay Methods

Introduction

Brian Cheng is a notable inventor based in Richmond, CA. He has made significant contributions to the field of biochemistry, particularly in the development of methods for assaying enzyme activity. His work has implications for understanding various pathologic conditions.

Latest Patents

Brian Cheng holds a patent for a method titled "Method for assaying the activity of spermidine/spermine N1-acetyltransferase." This innovative method involves the use of SSAT substrates to detect their acetylated forms. The substrates, which include rimantadine and tocainide, undergo metabolism through the action of the enzyme SSAT, resulting in the production of acetylated metabolites such as N-acetylrimantadine and N-acetyltocainide. The activity of SSAT can be correlated with various pathologic conditions, making this patent particularly valuable in medical research.

Career Highlights

Brian Cheng is currently employed at Biomark Technologies, Inc., where he continues to advance his research in enzyme assays. His work is characterized by a commitment to innovation and scientific excellence.

Collaborations

Brian collaborates with talented individuals in his field, including Rashid Bux and Daniel Sitar. Their combined expertise fosters a productive research environment that enhances the development of new technologies.

Conclusion

Brian Cheng is a distinguished inventor whose work in enzyme assay methods has the potential to impact medical research significantly. His contributions to the field exemplify the importance of innovation in advancing scientific knowledge.